|Bid||0.0000 x 1100|
|Ask||0.0000 x 1000|
|Day's Range||0.3250 - 0.3600|
|52 Week Range||0.2600 - 1.3000|
|Beta (3Y Monthly)||2.28|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Los Angeles-based company said it had a loss of 4 cents per share. Losses, adjusted to account for discontinued operations, were 5 cents per share. The company's shares closed at 52 cents. A year ago, ...
Zacks.com featured highlights include: Ralph Lauren, Estee Lauder, GMS, CytRx and T2 Biosystems
On a per-share basis, the Los Angeles-based company said it had a loss of 10 cents. The cancer drug developer posted revenue of $250,000 in the period. The company's shares closed at 75 cents. A year ago, ...
The Los Angeles-based company said it had a loss of 10 cents per share. The company's shares closed at $1.15. A year ago, they were trading at $3.78. _____ This story was generated by Automated Insights ...